{"id":4205,"date":"2026-05-12T13:45:00","date_gmt":"2026-05-12T11:45:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=e12f6838045c8bc9e9614141e036582d"},"modified":"2026-05-12T13:45:00","modified_gmt":"2026-05-12T11:45:00","slug":"kept-alive-by-ecmo-until-heart-transplant-sahara-romeros-story-of-survival-and-recovery-with-ecmolife-by-eurosets","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=4205","title":{"rendered":"Kept Alive by ECMO Until Heart Transplant: Sahara Romero’s Story of Survival and Recovery, with ECMOlife by Eurosets"},"content":{"rendered":"

MEDOLLA, Italy--(BUSINESS WIRE)--\u201cNow, for the first time in years, I can live without constantly fearing something could go wrong.\u201d<\/i> That's how Sahara Romero<\/b> told her story, presented at the EuroELSO Congress in Dublin<\/b> (6-8 May), dedicated to lifesaving extracorporeal therapies. Hers is a remarkable journey back to life, where clinical expertise and advanced life-support technologies came together to radically change her fate.<\/p><\/a><\/a><\/a><\/a>

\nSahara has lived with a serious heart condition since early adolescence<\/b>. The first signs of heart failure appeared when she was eleven. \u201cWhen I was doing simple activities, like gymnastics lessons, I got very tired and experienced pain in my chest. At first it wasn't clear what was happening.\u201d<\/i> That was the start of a routine of constant medical check-ups, daily limitations, and continual vigilance<\/b>.<\/p>

\nAs the years went by, the situation worsened. \u201cSahara had to rely on ECMO support on four different occasions<\/b>. The last time, in March 2023, her heart stopped working and she began to experience multi-organ failure. At that stage, the clinical goal was to maintain vital functions and stabilize the patient while awaiting a heart transplant,\u201d <\/i>explained Dr. Mario Andr\u00e9s Mercado D\u00edaz, critical care specialist at the Shaio Clinic in Bogot\u00e1.<\/b><\/p>

\nAt this critical stage, ECMOlife <\/b>played a central role. The system for extracorporeal life support was developed by Eurosets<\/b>, an Italian biomedical company. At the Shaio Clinic<\/b>, a cardiovascular center of excellence, ECMOlife became a critical component of Sahara's care<\/b>. \u201cThe technology enabled us to provide mechanical circulatory support, continuously monitor the patient's vital signs, and safely manage an extraordinarily complex clinical situation<\/i>,\" said Estefan\u00eda Giraldo Bejarano, a nurse specializing in ECMO<\/b>. \"We had to ensure that Sahara reached transplant in the best possible condition.\u201d<\/i><\/p>

\nAfter a difficult year marked by waiting and hope, during which Sahara \u2013 supported by ECMO \u2013 celebrated her birthday in hospital, the call finally came: a donor heart had become available<\/b>.<\/p>

\nToday, Sahara is living a normal life, an outcome that for years had seemed totally out of reach. \"Now I can think about tomorrow without being afraid.\u201d<\/i> Those words capture the true value of a complex clinical pathway: not just surviving, but getting back to living and doing the things people most want to do<\/b>.<\/p>

\nHer case highlights how advances in extracorporeal life-support technologies can offer precious time at the most critical moments, expanding treatment options. \u201cSolutions such as ECMO systems make it possible to tackle situations in which, until only a few years ago, the options were extremely limited, improving the prospects for patients' recovery and quality of life,\u201d<\/i> stressed Antonio Petralia, CEO of Eurosets.<\/b><\/p>

\nSahara's story embodies the true meaning of medical <\/i>expertise and innovation: showing how technology can become not an end in itself, but a silent ally in a patient's recovery.<\/p>

\nThe original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.<\/p> Contacts<\/b>

\nilenia.franchi@elettrapr.it<\/a>+39 393 9079914<\/p>","protected":false},"excerpt":{"rendered":"

MEDOLLA, Italy–(BUSINESS WIRE)–\u201cNow, for the first time in years, I can live without constantly fearing something could go wrong.\u201d That’s how Sahara Romero told her story, presented at the EuroELSO Congress in Dublin (6-8 May), dedicated to lifesavin…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4205","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/4205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4205"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/4205\/revisions"}],"predecessor-version":[{"id":4206,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/4205\/revisions\/4206"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}